Organ transplant patients routinely receive drugs that stop their immune systems from attacking newly implanted hearts, livers, kidney or lungs, which the body sees as foreign.
But new research at Washington University School of Medicine in St. Louis suggests that broadly dampening the immune response, long considered
But new research at Washington University School of Medicine in St. Louis suggests that broadly dampening the immune response, long considered